Filing Details
- Accession Number:
- 0001181431-13-048779
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-12 16:29:27
- Reporting Period:
- 2013-09-10
- Filing Date:
- 2013-09-12
- Accepted Time:
- 2013-09-12 16:29:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236927 | A Paul Friedman | Experimental Station Route 141 &Amp; Henry Clay Road Wilmington DE 19880 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-10 | 144,559 | $8.64 | 536,427 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-09-10 | 43,125 | $8.64 | 579,552 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-09-10 | 189,105 | $7.09 | 768,657 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-10 | 376,789 | $37.32 | 391,868 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-09-10 | 144,559 | $0.00 | 144,559 | $8.64 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-09-10 | 43,125 | $0.00 | 43,125 | $8.64 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-09-10 | 189,105 | $0.00 | 189,105 | $7.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-02-26 | No | 4 | M | Direct | |
| 0 | 2014-02-26 | No | 4 | M | Direct | |
| 0 | 2014-02-11 | No | 4 | M | Direct |
Footnotes
- Beginning February 27, 2004, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- Beginning February 12, 2007, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Represents weighted average sale price. Actual sales prices ranged from $36.50-$38.33.
- Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares
Billionaire Hedge Funds
